Wendy Sun
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (11)
Year:
2026
Higher‐order cognitive and affective functions are supported by large‐scale networks in the brain. Dysfunction in different networks is proposed to associate with distinct symptoms in neuropsychiatric disorders. However, the specific networks targeted by current clinical transcranial magnetic stimulation (TMS) approaches are unclear. While standard‐of‐care TMS relies on scalp‐based landmarks, recent FDA‐approved TMS protocols use individualized functional connectivity with the subgenual anterior cingulate cortex (sgACC) to optimize TMS targeting. Leveraging previous work on precision network estimation and modeling of the TMS electric field (E‐field), we asked whether various clinical TMS approaches target different functional networks between individuals. Results revealed that modeled homotopic scalp positions (left F3 and right F4) target different networks within and across individuals, and right F4 generally favors a right‐lateralized control network. TMS coil positions over the dorsolateral prefrontal cortex (dlPFC) zone anticorrelated with the sgACC most frequently target a network coupled to the ventral striatum (reward circuitry) but largely miss that network in some individuals. We further illustrate how modeling can be used to retrospectively assess the estimated targets achieved in prior TMS sessions and also used to prospectively provide coil positions that can target distinct closely localized dlPFC network regions with spatial selectivity and maximal E‐field intensity. In a final study, precision targeting was found to be feasible in participants with Major Depressive Disorder using data derived from a single low‐burden MRI session suggesting the methods are applicable to translational efforts where limiting patient burden and ensuring robustness are critical.
Year:
2025
Year:
2025
Roughly one-third of patients with major depressive disorder (MDD) fail to respond to standard treatments and develop treatment-resistant MDD. For these patients, alternative therapies ofer additional options but yield inconsistent outcomes. Progress has been limited by the absence of objective, brain-based biomarkers to guide target selection or track therapeutic response in real time. Instead, clinicians rely on behavioral assessments that evolve slowly over weeks to months, obscuring the underlying neural dynamics of symptom changes. Here, we test whether the aperiodic exponent of intracranial EEG (iEEG) local field potentials can serve as a neurophysiological marker of depression symptom severity. We leveraged a large iEEG cohort (N = 20) undergoing invasive monitoring for refractory epilepsy, yielding over 1,800 contacts spanning cortical and subcortical zones. For each contact, we estimated the aperiodic exponent (thought to reflect aspects of cortical excitability) of the power spectrum across 10-100 Hz within local brain regions and across distributed cortical association networks. Depressive symptoms were assessed with the Beck Depression Inventory-II (BDI-II) immediately before intracranial resting state recordings. With respect to the BDI-II scale, participants were identified as experiencing minimal (BDI-II ≤ 13) or elevated depression symptoms (BDI-II ≥ 14). Associations between symptom severity (BDI-II total score and Somatic-Afective, Cognitive, and Anhedonia subscales) and region- or network-level exponents were modeled with ordinary least squares (OLS) regression. The whole-brain, mean aperiodic exponent for each participant discriminated symptom status (AUC = 0.81). At the regional level, the orbitofrontal cortex, anterior cingulate cortex, insula, and amygdala showed higher exponents in the elevated depression symptom group (d = 1.18-1.71; p = 0.032-0.004). A post-hoc classification analysis across these four regions misclassified one participant per group (AUC = 0.86; 95% CI 0.64-1.00). In continuous analyses, BDI-II scores correlated positively with exponents in these same four regions (pFDR = 0.019-0.027; partial r=0.61–0.70) and at the network level in the Salience network (pFDR = 0.024; partial r = 0.63) and Default (pFDR = 0.046; partial r = 0.55) network. The Salience network significantly tracked Anhedonia symptoms (p = 0.004; partial r = 0.62). Here we report that intracranial aperiodic exponents within fronto-limbic and insular circuits, overlapping with networks implicated in contemporary accounts of depression pathophysiology, diferentiate depressive symptom status and scale with severity. These findings support the aperiodic exponent as a candidate neurophysiological marker of current depression symptom burden, with potential relevance for individualized neuromodulation in MDD.
Year:
2025
Precision neuroimaging was used to explore specialization for verbal versus nonverbal processing. Consistent with prior findings, individuals exhibited a spatially left-lateralized association language network, with regions in both hemispheres robustly responding to processing of meaning-based sentences. We next examined differential responses to verbal (words) versus nonverbal (faces) materials within the same working memory task. The right hemisphere components of the language network responded more strongly to nonverbal than to verbal materials, splitting the network’s functional profile between the hemispheres. Similar patterns were observed across multiple association networks including putative cognitive-control, action-mode, and attention networks. The hemispheric laterality effect was prospectively replicated in a second independent study. These findings highlight a generalized laterality phenomenon that transcends individual specialized networks and aligns with a broad mechanism that modulates processing between the hemispheres.
Year:
2025
Objective To characterize the type and distribution of epileptiform activity across anatomical regions and functional networks in a large cohort of patients with drug-resistant epilepsy (DRE) undergoing intracranial electroencephalography (iEEG). Methods We retrospectively reviewed iEEG recordings from 93 patients with DRE who underwent stereoelectroencephalography at our institution between 2019 and 2025. Epileptiform activity was classified as “ictal”, “interictal”, or “ictal spread” based on visual inspection and clinical correlation. Electrode coordinates were localized to anatomical regions using the Brainnetome Atlas and to functional networks using the DU15NET-Consensus Atlas . The distribution of epileptiform activity across regions and networks was compared with global baselines using Chi-square tests with false discovery rate correction. Results Interictal discharges were the most prevalent type of epileptiform activity (median 9.5% of contacts per patient), followed by ictal (6.0%) and ictal spread (2.1%). Temporal regions exhibited an increased prevalence of all types of epileptiform activity compared to the global baseline, whereas frontal regions showed marked reductions, despite dense sampling. At the network level, epileptiform activity was overrepresented in Default Network-A and underrepresented in the Salience/Parietal Memory Network. Significance Epileptiform activity shows consistent, non-uniform patterns across both anatomical regions and functional networks. These findings reinforce the central role of the temporal lobe and associative networks in epileptogenesis and support the view of epilepsy as a disorder of distributed brain networks. Mapping epileptiform activity in a network framework may enhance biomarker development and inform circuit-based surgical and neuromodulatory treatment strategies.
Year:
2025
The organization of cerebral networks was estimated within individuals with intensive, repeat sampling of fMRI data. A hierarchical organization emerged in each individual that delineated first-, second-, and third-order cortical networks. Regions of distinct third-order association networks consistently exhibited side-by-side juxtapositions that repeated across multiple cortical zones, with clear and robust functional specialization among the embedded regions.
Year:
2024
Higher-order cognitive and affective functions are supported by large-scale networks in the brain. Dysfunction in different networks is proposed to associate with distinct symptoms in neuropsychiatric disorders. However, the specific networks targeted by current clinical transcranial magnetic stimulation (TMS) approaches are unclear. While standard-of-care TMS relies on scalp-based landmarks, recent FDA-approved TMS protocols use individualized functional connectivity with the subgenual anterior cingulate cortex (sgACC) to optimize TMS targeting. Leveraging previous work on precision network estimation and recent advances in network-level TMS targeting, we demonstrate that clinical TMS approaches target different functional networks between individuals. Homotopic scalp positions (left F3 and right F4) target different networks within and across individuals, and right F4 generally favors a right-lateralized control network. We also modeled the impact of targeting the dorsolateral prefrontal cortex (dlPFC) zone anticorrelated with the sgACC and found that the individual-specific anticorrelated region variably targets a network coupled to reward circuitry. Combining individualized, precision network mapping and electric field (E-field) modeling, we further illustrate how modeling can be deployed to prospectively target distinct closely localized association networks in the dlPFC with meaningful spatial selectivity and E-field intensity and retrospectively assess network engagement. Critically, we demonstrate the feasibility and reliability of this approach in an independent cohort of participants (including those with Major Depressive Disorder) who underwent repeated sessions of TMS to distinct networks, with precise targeting derived from a low-burden single session of data. Lastly, our findings emphasize differences between selectivity and maximal intensity, highlighting the need to consider both metrics in precision TMS efforts.
Year:
2024
Year:
2023
Year:
2021
Year:
2020
Collaborators (9)
Lauren DiNicola
Assistant Professor
University of Virginia
Mark Eldaief
Assistant Professor
Massachusetts General Hospital
Ben Shofty
-
Rodrigo M. Braga
Assistant Professor
Northwestern University
Jingnan Du
Assistant Professor
University of Notre Dame
Shervin Rahimpour
Assistant Professor
University of Utah
Elliot Smith
Assistant Professor
University of Utah
Randy Buckner
Solsland Family Professor of Psychology and Neuroscience
Harvard University
David Izquierdo-Garcia
Massachusetts Institute of Technology
Make your next move.
Prepare your application
Review drafts before you send them.